v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Sales Agreement
Common Stock
Common Stock
Sales Agreement
Additional Paid-in Capital
Additional Paid-in Capital
Sales Agreement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 265,525   $ 5   $ 654,986   $ (907) $ (388,559)
Beginning Balance, Shares at Dec. 31, 2023     47,666,438          
Vesting of restricted shares, Shares     517,604          
Stock - based compensation 11,255       11,255      
Issuance of common stock under share-based compensation arrangements 790       790      
Issuance of common stock under share-based compensation arrangements Shares     88,860          
Issuance of common stock   $ 14,887       $ 14,887    
Sale of common stock       1,016,950        
Unrealized (loss) gain on marketable securities (111)           (111)  
Pension and other postemployment benefits 81           81  
Net loss (87,497)             (87,497)
Ending Balance at Jun. 30, 2024 204,930   $ 5   681,918   (937) (476,056)
Ending Balance, Shares at Jun. 30, 2024     49,289,852          
Beginning Balance at Mar. 31, 2024 238,909   $ 5   675,242   (950) (435,388)
Beginning Balance, Shares at Mar. 31, 2024     49,055,192          
Vesting of restricted shares, Shares     168,165          
Stock - based compensation 6,061       6,061      
Issuance of common stock under share-based compensation arrangements 615       615      
Issuance of common stock under share-based compensation arrangements Shares     66,495          
Unrealized (loss) gain on marketable securities 10           10  
Pension and other postemployment benefits 3           3  
Net loss (40,668)             (40,668)
Ending Balance at Jun. 30, 2024 204,930   $ 5   681,918   (937) (476,056)
Ending Balance, Shares at Jun. 30, 2024     49,289,852          
Beginning Balance at Dec. 31, 2024 154,486   $ 5   691,447   (1,140) (535,826)
Beginning Balance, Shares at Dec. 31, 2024     49,719,448          
Vesting of restricted shares, Shares     406,093          
Stock - based compensation 4,759       4,759      
Sale of common stock   1,016,950            
Unrealized (loss) gain on marketable securities (137)           (137)  
Pension and other postemployment benefits 38           38  
Net loss (11,327)             (11,327)
Ending Balance at Jun. 30, 2025 147,819   $ 5   696,206   (1,239) (547,153)
Ending Balance, Shares at Jun. 30, 2025     50,125,541          
Beginning Balance at Mar. 31, 2025 150,913   $ 5   693,876   (1,081) (541,887)
Beginning Balance, Shares at Mar. 31, 2025     50,100,675          
Vesting of restricted shares, Shares     24,866          
Stock - based compensation 2,330       2,330      
Unrealized (loss) gain on marketable securities (158)           (158)  
Net loss (5,266)             (5,266)
Ending Balance at Jun. 30, 2025 $ 147,819   $ 5   $ 696,206   $ (1,239) $ (547,153)
Ending Balance, Shares at Jun. 30, 2025     50,125,541